RDY FY 2007 Earnings Report — Dr. Reddy's Laboratories Limited Revenue & Financial Results | Market Cap Arena

Dr. Reddy's Laboratories LimitedRDY

FY 2007 Earnings

Reported September 26, 2007

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$692M	—	$258M	—	168.2%
Op. Income	$119M	—	$15M	—	678.3%
Gross Margin	47.4%	—	48.8%	—	-1.4pp
Net Margin	14.3%	—	6.7%	—	7.6pp
EPS (Diluted)	$0.62	—	$0.11	—	448.1%
Free Cash Flow	$75M	—	-$3M	—	2701.4%

Revenue Flow

Item	Amount
REVENUE	$692M
Cost of Revenue	$364M
GROSS PROFIT	$328M
R&D Expenses	$26M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$149M
Other Expenses	$33M
Operating Expenses	$209M
Cost & Expenses	$573M
OPERATING INCOME	$119M
Interest Income	$0
Interest Expense	$0
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$112M
Income Tax Expense	$13M
Net Income from Continuing Ops	$99M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$99M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$99M
D&A	$32M
EBIT	$119M
EBITDA	$151M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$692M
Cost of Revenue	$364M
GROSS PROFIT	$328M
R&D Expenses	$26M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$149M
Other Expenses	$33M
Operating Expenses	$209M
Cost & Expenses	$573M
OPERATING INCOME	$119M
Interest Income	$0
Interest Expense	$0
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$112M
Income Tax Expense	$13M
Net Income from Continuing Ops	$99M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$99M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$99M
D&A	$32M
EBIT	$119M
EBITDA	$151M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$99M
Depreciation & Amortization	$32M
Stock-Based Compensation	$2M
Deferred Income Tax	-$12M
Other Non-Cash Items	$37M
Change in Working Capital	-$32M
OPERATING CASH FLOW	$126M
Capital Expenditure	-$50M
Acquisitions (Net)	$893.7K
Purchases of Investments	-$5M
Sales/Maturities of Investments	$4M
Other Investing Activities	$57M
NET CASH FROM INVESTING	$6M
Net Debt Issuance	-$83M
Common Stock Repurchased	$0
Common Dividends Paid	-$5M
Other Financing Activities	-$840.5K
NET CASH FROM FINANCING	$19M
FREE CASH FLOW	$75M
Net Change in Cash	$152M

Balance Sheet

Item	Amount
Cash & Equivalents	$191M
Short-Term Investments	$163.2K
Net Receivables	$81M
Inventory	$80M
Other Current Assets	$47M
TOTAL CURRENT ASSETS	$398M
PP&E (Net)	$132M
Goodwill	$165M
Intangible Assets	$201M
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$17M
TOTAL NON-CURRENT ASSETS	$515M
TOTAL ASSETS	$914M
Account Payables	$51M
Short-Term Debt	$39M
Deferred Revenue	$6M
Other Current Liabilities	$65M
TOTAL CURRENT LIABILITIES	$197M
Long-Term Debt	$190M
Deferred Revenue NC	$915.5K
Deferred Tax Liabilities	$80M
Other Non-Current Liabilities	$3M
TOTAL NON-CURRENT LIABILITIES	$274M
TOTAL LIABILITIES	$471M
Common Stock	$9M
Additional Paid-In Capital	$212M
Retained Earnings	$214M
Treasury Stock	$0
Accum. Other Comp. Income	$8M
Other Equity	$14M
TOTAL STOCKHOLDERS' EQUITY	$442M
Minority Interest	$111.4K
TOTAL EQUITY	$442M
TOTAL LIABILITIES & EQUITY	$914M
Total Debt	$263M
Net Debt	$72M